QCM
CRL icon

QRG Capital Management’s Charles River Laboratories CRL Stock Holding History

QRG Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$495K Buy
2,183
+255
+13% +$45.4K ﹤0.01% 863
2026
Q1 		$333K Sell
1,928
-344
-15% -$63.8K ﹤0.01% 915
2025
Q4 		$453K Buy
2,272
+301
+15% +$54.6K 0.01% 786
2025
Q3 		$308K Sell
1,971
-206
-9% -$32.7K ﹤0.01% 872
2025
Q2 		$330K Buy
2,177
+620
+40% +$82.7K ﹤0.01% 935
2025
Q1 		$234K Buy
1,557
+175
+13% +$29.3K ﹤0.01% 977
2024
Q4 		$255K Buy
+1,382
New +$266K ﹤0.01% 957
2024
Q2 		– Sell
-1,047
Closed -$284K – 1040
2024
Q1 		$284K Buy
+1,047
New +$250K ﹤0.01% 907

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

QRG Capital Management's CRL Position: Q2 2026 in Review

QRG Capital Management increased its Charles River Laboratories (CRL) stake by 13% in Q2 2026, buying an estimated $45.4K and bringing the position to 2,183 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #863.

QRG Capital Management first reported a position in CRL in Q1 2024 and has held it in 8 quarters since. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • QRG Capital Management held 2,183 shares of Charles River Laboratories worth $495K as of Q2 2026.
  • QRG Capital Management bought 255 Charles River Laboratories shares in Q2 2026, an estimated $45.4K.
  • Charles River Laboratories made up ﹤0.01% of QRG Capital Management's portfolio in Q2 2026, its #863 holding.
  • QRG Capital Management first reported a position in Charles River Laboratories in Q1 2024 and has held it in 8 quarters since.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.